GlycoNex Submits Denosumab Biosimilar SPD8 for Regulatory Approval in Japan
Subject to regulatory review and approval, SPD8 could receive marketing approval in Japan by the end of 2027, paving the way for its commercial launch.
Taiwan | 09/11/2026 | By Abha Rustagi
Cenra Healthcare has announced the expansion of its long-standing partnership with Dr. Reddy’s Laboratories (Taiwan) Ltd. to further improve access to affordable and clinically valuable treatments for patients in Taiwan.
Taiwan | 22/07/2025 | By Dineshwori | 331
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy